Next Generation Tissue Biomarkers Market Expansion Forecast Reaching $1.96 Billion By 2030 At 9.3% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Next Generation Tissue Biomarkers Market Compare Between 2026 And 2030?
The next generation tissue biomarkers market has experienced rapid expansion in recent years. It is anticipated to grow from $3.03 billion in 2025 to $3.42 billion in 2026, at a compound annual growth rate (CAGR) of 12.9%. The growth observed in prior periods is attributable to factors such as reliance on traditional histopathology techniques, restricted methods for biomarker identification, escalating oncology research, increasing adoption of companion diagnostics, and initial investment in genomic and proteomic studies.
The next generation tissue biomarkers market is poised for significant expansion in the coming years, with its size projected to reach $5.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. This anticipated growth throughout the forecast period can be ascribed to progress in next-generation sequencing technologies, the integration of AI-driven tissue analysis, the expansion of spatial biology platforms, increasing investment in multi-omics research, and greater collaboration between pharmaceutical companies and academic institutions. Prominent trends for this period include the wider adoption of spatial biology and multi-omics approaches, increased utilization of digital pathology and AI analysis in diagnostics, a surging demand for biomarkers in oncology and companion diagnostics, enhanced drug discovery and development utilizing tissue biomarkers, and the incorporation of transcriptomic and metabolomic biomarkers for precision medicine applications.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27363&type=smp
Which Primary Drivers Are Impacting The Next Generation Tissue Biomarkers Market Growth?
The growing need for personalized medicine is anticipated to fuel the expansion of the next generation tissue biomarkers market in the coming years. This medical strategy involves customizing therapies according to an individual’s genetic profile, lifestyle choices, and environmental influences. Its increasing acceptance stems from ongoing progress in genomic technologies, which enable the creation of highly precise and unique treatment plans. This demand for personalized medicine is accelerating the advancement of next-generation tissue biomarkers, given their capability to offer accurate and customized data essential for adapting treatments to each patient’s distinct tissue characteristics. For example, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, indicated that in 2023, the FDA sanctioned 16 new personalized treatments specifically for rare disease patients, marking an increase from 6 in 2022. Among these newly approved personalized treatments for 2023 were also seven cancer drugs and three for other diseases and conditions. Consequently, the escalating need for personalized medicine is propelling the growth of the next generation tissue biomarkers market.
How Is The Next Generation Tissue Biomarkers Market Segmented Across Different Segment Categories?
The next generation tissue biomarkers market covered in this report is segmented –
1) By Type: Genomic Biomarkers, Proteomic Biomarkers, Epigenetic Biomarkers, Transcriptomic Biomarkers, Metabolomic Biomarkers
2) By Technology: Immunohistochemistry, Next-Generation Sequencing, Mass Spectrometry (Ms)-Based Proteomics, Spatial Biology Platforms, Digital Pathology And Artificial Intelligence Analysis, Other Technologies
3) By Application: Oncology, Companion Diagnostics, Drug Discovery And Development, Neurology, Other Applications
4) By End Use: Hospitals And Reference Labs, Pharma And Biotech Companies, Academic And Research Institutes, Contract Research Organizations
Subsegments:
1) By Genomic Biomarkers: Single Nucleotide Polymorphisms, Copy Number Variations, Gene Fusions
2) By Proteomic Biomarkers: Protein Expression Levels, Post-Translational Modifications, Protein-Protein Interactions
3) By Epigenetic Biomarkers: Histone Modification Patterns, Chromatin Remodeling Biomarkers, Non-Coding Ribonucleic Acid Regulation
4) By Transcriptomic Biomarkers: Long Non-Coding Ribonucleic Acids, Circular Ribonucleic Acids, Alternative Splicing Variants
5) By Metabolomic Biomarkers: Lipid Profiles, Amino Acid Signatures, Organic Acids
What Trends Are Influencing The Evolution Of The Next Generation Tissue Biomarkers Market?
Leading firms within the next generation tissue biomarkers market are concentrating on creating sophisticated offerings, including genomic-based diagnostic assays and sequencing solutions, aiming to improve the precision, rapidity, and individualized nature of diagnosing and treating cancer. These genomic-based diagnostic assays and sequencing solutions involve methods and instruments for analyzing genetic data to pinpoint biomarkers linked to diseases, thereby facilitating more accurate and tailored strategies for diagnosis and therapy. An example of this is Illumina Inc., a US-based biotechnology company, which in August 2024, secured FDA approval for its TruSight Oncology Comprehensive test, alongside two companion diagnostics, designed to quickly connect cancer patients with appropriate targeted therapies. This test analyzes more than 500 genes from a single tissue sample, allowing for precise treatment selection across different solid tumors. It automates biomarker detection and supports 24/7 deployment, leading to a substantial reduction in turnaround times and an improvement in clinical efficiency, thus offering a contemporary method for optimizing cancer diagnostics within a regulated system.
Which Organizations Play A Role In The Next Generation Tissue Biomarkers Market Landscape?
Major companies operating in the next generation tissue biomarkers market are Roche Diagnostics, Thermo Fisher Scientific Inc., LabCorp., Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Myriad Genetics Inc., NeoGenomics Laboratories Inc., Foundation Medicine Inc., NanoString Technologies Inc., PathAI Inc., Biocartis Group NV, Personalis Inc., Ultivue Inc., Indica Labs Inc., Strata Oncology Inc., Genialis Inc., Alida Biosciences Inc., Biofidelity Ltd.
Get The Full Next Generation Tissue Biomarkers Market Report:
Which Region Is The Largest In The Next Generation Tissue Biomarkers Market?
North America was the largest region in the next generation tissue biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation tissue biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Next Generation Tissue Biomarkers Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Next Generation Tissue Biomarkers Market 2026, By The Business Research Company
Nail Care Products Market Report 2026
https://www.thebusinessresearchcompany.com/report/nail-care-products-global-market-report
Nail Salon Market Report 2026
https://www.thebusinessresearchcompany.com/report/nail-salon-global-market-report
Nail Polish Market Report 2026
https://www.thebusinessresearchcompany.com/report/nail-polish-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
